In order to gauge the impact of the KLF4K409Q mutation on cellular pathways, we performed transcriptomic analysis of 7 KLF4K409Q and 10 KLF4wt meningiomas (all WHO I° and AKT1 wildtype) matched by patient sex, age and tumor location. The gene discussed is AKT1; the disease is meningioma.